Distillate Capital Partners LLC grew its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 19.7% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 143,861 shares of the healthcare conglomerate's stock after acquiring an additional 23,635 shares during the quarter. UnitedHealth Group comprises 3.6% of Distillate Capital Partners LLC's investment portfolio, making the stock its biggest holding. Distillate Capital Partners LLC's holdings in UnitedHealth Group were worth $72,774,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Western Pacific Wealth Management LP raised its holdings in UnitedHealth Group by 2.2% during the fourth quarter. Western Pacific Wealth Management LP now owns 902 shares of the healthcare conglomerate's stock worth $456,000 after purchasing an additional 19 shares in the last quarter. MCF Advisors LLC boosted its stake in shares of UnitedHealth Group by 0.8% in the fourth quarter. MCF Advisors LLC now owns 2,578 shares of the healthcare conglomerate's stock valued at $1,304,000 after buying an additional 20 shares in the last quarter. Axiom Financial Strategies LLC raised its position in UnitedHealth Group by 3.6% in the fourth quarter. Axiom Financial Strategies LLC now owns 575 shares of the healthcare conglomerate's stock worth $291,000 after acquiring an additional 20 shares in the last quarter. Richwood Investment Advisors LLC boosted its position in shares of UnitedHealth Group by 0.4% during the 4th quarter. Richwood Investment Advisors LLC now owns 5,247 shares of the healthcare conglomerate's stock worth $2,654,000 after purchasing an additional 20 shares in the last quarter. Finally, 44 Wealth Management LLC increased its holdings in shares of UnitedHealth Group by 1.6% in the 4th quarter. 44 Wealth Management LLC now owns 1,309 shares of the healthcare conglomerate's stock valued at $662,000 after purchasing an additional 21 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.
Wall Street Analyst Weigh In
Several brokerages recently issued reports on UNH. KeyCorp reaffirmed an "overweight" rating and set a $650.00 price objective on shares of UnitedHealth Group in a report on Friday, January 17th. Mizuho lifted their target price on shares of UnitedHealth Group from $600.00 to $650.00 and gave the stock an "outperform" rating in a research report on Wednesday, April 9th. Truist Financial raised their price objective on shares of UnitedHealth Group from $610.00 to $660.00 and gave the stock a "buy" rating in a research note on Friday. Piper Sandler lowered their target price on UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating on the stock in a report on Thursday, January 2nd. Finally, StockNews.com upgraded UnitedHealth Group from a "hold" rating to a "buy" rating in a research report on Thursday, January 23rd. Twenty-one investment analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company's stock. According to data from MarketBeat, UnitedHealth Group presently has a consensus rating of "Buy" and an average target price of $632.85.
Read Our Latest Report on UnitedHealth Group
Insider Transactions at UnitedHealth Group
In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,000 shares of UnitedHealth Group stock in a transaction that occurred on Friday, January 17th. The stock was acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the purchase, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.33% of the stock is currently owned by company insiders.
UnitedHealth Group Price Performance
UNH stock traded down $13.24 on Monday, hitting $586.23. 4,838,165 shares of the company's stock traded hands, compared to its average volume of 4,346,637. The stock has a market cap of $536.23 billion, a price-to-earnings ratio of 37.82, a P/E/G ratio of 1.37 and a beta of 0.61. UnitedHealth Group Incorporated has a 1-year low of $438.50 and a 1-year high of $630.73. The stock has a fifty day moving average of $512.87 and a 200-day moving average of $541.80. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.
UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping analysts' consensus estimates of $6.74 by $0.07. The firm had revenue of $100.81 billion for the quarter, compared to analysts' expectations of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. UnitedHealth Group's revenue was up 6.8% on a year-over-year basis. During the same quarter last year, the business posted $5.83 EPS. On average, analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.
UnitedHealth Group Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.43%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group's payout ratio is presently 54.19%.
UnitedHealth Group Company Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Further Reading

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.